Evidence map›Paper›PMID 29850558›Full record

ArticleBioMed research international2018

MicroRNA Expression Profiling in Psoriatic Arthritis.

Andrea Pelosi, Claudio Lunardi, Piera Filomena Fiore, Elisa Tinazzi, Giuseppe Patuzzo, Giuseppe Argentino, Francesca Moretta, Antonio Puccetti, Marzia Dolcino

Open access · hybridAbstract read
In one paragraph

Article in BioMed research international, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. miR-574-5p in epigenetic regulation and Toll-like receptor signaling.Cell communication and signaling : CCS · 2024
    Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Advances of Genomic Medicine in Psoriatic Arthritis.Journal of personalized medicine · 2022
    Review
  11. Review
  12. Review
  13. Article
  14. Review
  15. Molecular Biology Approaches to Understanding Spondyloarthritis.Rheumatic diseases clinics of North America · 2020
    Review
  16. Article
  17. Plasma MicroRNA Expression Profiles in Psoriasis.Journal of immunology research · 2020
    Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Andrea PelosiImmunology Area, Pediatric Hospital Bambino Gesù, Viale San Paolo 15, 00146 Rome, Italy.ORCID 0000-0003-2308-9215
Claudio LunardiDepartment of Medicine, University of Verona, Piazzale L.A. Scuro 10, 37134 Verona, Italy.ORCID 0000-0001-6446-2990
Piera Filomena FioreImmunology Area, Pediatric Hospital Bambino Gesù, Viale San Paolo 15, 00146 Rome, Italy.ORCID 0000-0002-6810-2172
Elisa TinazziDepartment of Medicine, University of Verona, Piazzale L.A. Scuro 10, 37134 Verona, Italy.
Giuseppe PatuzzoDepartment of Medicine, University of Verona, Piazzale L.A. Scuro 10, 37134 Verona, Italy.
Giuseppe ArgentinoDepartment of Medicine, University of Verona, Piazzale L.A. Scuro 10, 37134 Verona, Italy.
Francesca MorettaDepartment of Medicine, University of Verona, Piazzale L.A. Scuro 10, 37134 Verona, Italy.
Antonio PuccettiImmunology Area, Pediatric Hospital Bambino Gesù, Viale San Paolo 15, 00146 Rome, Italy.ORCID 0000-0002-2869-5698
Marzia DolcinoDepartment of Medicine, University of Verona, Piazzale L.A. Scuro 10, 37134 Verona, Italy.ORCID 0000-0001-7769-7799
University of Verona · ITBambino Gesù Children's Hospital · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPsoriatic arthritis (PsA) is an inflammatory arthritis, characterized by bone erosions and new bone formation. MicroRNAs (miRNAs) are key regulators of the immune responses. Differential expression of miRNAs has been reported in several inflammatory autoimmune diseases; however, their role in PsA is not fully elucidated. We aimed to identify miRNA expression signatures associated with PsA and to investigate their potential implication in the disease pathogenesis.

methodsmiRNA microarray was performed in blood cells of PsA patients and healthy controls. miRNA pathway analyses were performed and the global miRNA profiling was combined with transcriptome data in PsA. Deregulation of selected miRNAs was validated by real-time PCR.

resultsWe identified specific miRNA signatures associated with PsA patients with active disease. These miRNAs target pathways relevant in PsA, such as TNF, MAPK, and WNT signaling cascades. Network analysis revealed several miRNAs regulating highly connected genes within the PsA transcriptome. miR-126-3p was the most downregulated miRNA in active patients. Noteworthy, miR-126 overexpression induced a decreased expression of genes implicated in PsA.

conclusionsThis study sheds light on some epigenetic aspects of PsA identifying specific miRNAs, which may represent promising candidates as biomarkers and/or for the design of novel therapeutic strategies in PsA.

Indexed as

AdultArthritis, PsoriaticBiomarkersFemaleGene Expression ProfilingHumansJurkat CellsMaleMicroRNAsMiddle AgedSignal TransductionTranscriptomeBiomarkersMicroRNAs

Identifiers

PMID29850558
PMCPMC5937573
OpenAlexW2801069673

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.